Literature DB >> 18484658

Alcohol dehydrogenase (ADH) isoenzymes and aldehyde dehydrogenase (ALDH) activity in the sera of patients with liver cancer.

Wojciech Jelski1, Bogdan Zalewski, Maciej Szmitkowski.   

Abstract

The principal enzymes catalyzing the conversion of ethanol to acetate are alcohol dehydrogenase (ADH) and aldehyde dehydrogenase (ALDH). The activities of these enzymes are elevated in the serum during the course of alcoholism or cirrhosis. In previous investigations we have found elevated levels of ADH, ALDH, and class I ADH activity in liver cancer cells. It can suggest that these changes may be reflected by enzyme activity in the serum. In this work, the activity of ADH isoenzymes, and ALDH in the sera of patients with liver cancer was measured. Serum samples were taken from 64 patients (28 drinkers, 36 nondrinkers), with liver cancer. 25 patients had primary and 39 metastatic liver tumors. Total ADH activity was measured by photometric method with p-nitrosodimethylaniline (NDMA) as a substrate and ALDH activity by the fluorimetric method with 6-methoxy-2-naphtaldehyde as a substrate. For the measurement of the activity of class I and II isoenzymes we employed the fluorimetric methods, with class-specific fluorogenic substrates. The activity of class III ADH was measured by the photometric method with formaldehyde and class IV with m-nitrobenzaldehyde as a substrate. A statistically significant increase of class I ADH isoenzymes was found in the sera of cancer patients. The median activity of this class isoenzyme in the total cancer group increased about 51% (2.94 mU/L) in the comparison to the control level (1.43 mU/L). The activity of the class I ADH isoenzyme was significantly higher in the sera of patients with metastatic tumors than with primary cancers. The activity of this class in the sera of drinkers and group of moderate drinkers was significantly higher in comparison to the control group and higher in the sera of heavy drinkers when compared with moderate drinking patients. The total ADH activity was significantly higher (44%) among patients with cancer than healthy ones. The activity of class I ADH isoenzymes was elevated only in the serum of patients with metastatic liver cancer. This increase of activity seems to be caused by the enzyme released from liver cancer cells and primary tumors originating in other organs. (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18484658      PMCID: PMC6648982          DOI: 10.1002/jcla.20241

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  20 in total

1.  Human alcohol dehydrogenase isoenzyme activity in the sera of non-alcoholic liver cirrhotic patients.

Authors:  L Chrostek; M Szmitkowski
Journal:  Eur J Clin Chem Clin Biochem       Date:  1996-10

2.  [Influence of pyridoxal phosphate in measuring aminotransferases activities in patients with viral hepatitis].

Authors:  G Férard; F Imbert-Bismut; D Messous; A Piton; A Abella; P Burnat; B Hainque; N Glasser; J M Lessinger
Journal:  Ann Biol Clin (Paris)       Date:  2004 Nov-Dec       Impact factor: 0.459

3.  Serum alcohol dehydrogenase, an indicator of intrahepatic cholestasis.

Authors:  E Mezey; G R Cherrick; P R Holt
Journal:  N Engl J Med       Date:  1968-08-01       Impact factor: 91.245

4.  Identification of a human stomach alcohol dehydrogenase with distinctive kinetic properties.

Authors:  S J Yin; M F Wang; C S Liao; C M Chen; C W Wu
Journal:  Biochem Int       Date:  1990-12

5.  Distribution of alcohol dehydrogenase isoenzymes in the human liver acinus.

Authors:  I P Maly; M Toranelli; D Sasse
Journal:  Histochem Cell Biol       Date:  1999-05       Impact factor: 4.304

6.  Ethnic differences in gastric sigma-alcohol dehydrogenase activity and ethanol first-pass metabolism.

Authors:  K Dohmen; E Baraona; H Ishibashi; G Pozzato; M Moretti; C Matsunaga; K Fujimoto; C S Lieber
Journal:  Alcohol Clin Exp Res       Date:  1996-12       Impact factor: 3.455

7.  Evidence for the identity of glutathione-dependent formaldehyde dehydrogenase and class III alcohol dehydrogenase.

Authors:  M Koivusalo; M Baumann; L Uotila
Journal:  FEBS Lett       Date:  1989-10-23       Impact factor: 4.124

Review 8.  Polymorphism of aldehyde dehydrogenase and alcohol sensitivity.

Authors:  H W Goedde; D P Agarwal
Journal:  Enzyme       Date:  1987

9.  Hepatic aldehyde and alcohol dehydrogenases in alcohol-preferring and alcohol-avoiding rat lines.

Authors:  T Koivisto; C J Eriksson
Journal:  Biochem Pharmacol       Date:  1994-10-18       Impact factor: 5.858

10.  The activity of class I, II, III, and IV of alcohol dehydrogenase isoenzymes and aldehyde dehydrogenase in pancreatic cancer.

Authors:  Wojciech Jelski; Lech Chrostek; Maciej Szmitkowski
Journal:  Pancreas       Date:  2007-08       Impact factor: 3.327

View more
  16 in total

1.  The activity of class I, II, III, and IV alcohol dehydrogenase isoenzymes and aldehyde dehydrogenase in endometrial cancer.

Authors:  Karolina Orywal; Wojciech Jelski; Michał Zdrodowski; Maciej Szmitkowski
Journal:  J Clin Lab Anal       Date:  2010       Impact factor: 2.352

2.  Proteomic analysis of differentially expressed proteins in peripheral cholangiocarcinoma.

Authors:  Ian A Darby; Karine Vuillier-Devillers; Emilie Pinault; Vincent Sarrazy; Sébastien Lepreux; Charles Balabaud; Paulette Bioulac-Sage; Alexis Desmoulière
Journal:  Cancer Microenviron       Date:  2010-06-26

Review 3.  Alcohol dehydrogenase and aldehyde dehydrogenase in malignant neoplasms.

Authors:  Karolina Orywal; Maciej Szmitkowski
Journal:  Clin Exp Med       Date:  2016-02-17       Impact factor: 3.984

4.  Release and uptake of volatile organic compounds by human hepatocellular carcinoma cells (HepG2) in vitro.

Authors:  Paweł Mochalski; Andreas Sponring; Julian King; Karl Unterkofler; Jakob Troppmair; Anton Amann
Journal:  Cancer Cell Int       Date:  2013-07-17       Impact factor: 5.722

5.  Identification of Circulating Biomarker Candidates for Hepatocellular Carcinoma (HCC): An Integrated Prioritization Approach.

Authors:  Faryal Mehwish Awan; Anam Naz; Ayesha Obaid; Amjad Ali; Jamil Ahmad; Sadia Anjum; Hussnain Ahmed Janjua
Journal:  PLoS One       Date:  2015-09-28       Impact factor: 3.240

6.  The activity of alcohol dehydrogenase (ADH) isoenzymes and aldehyde dehydrogenase (ALDH) in the sera of patients with brain cancer.

Authors:  Wojciech Jelski; Magdalena Laniewska-Dunaj; Karolina Orywal; Jan Kochanowicz; Robert Rutkowski; Maciej Szmitkowski
Journal:  Neurochem Res       Date:  2014-10-10       Impact factor: 3.996

7.  Comments on the "Prognostic Impact and Clinicopathological Correlation of CD133 and ALDH1 Expression in Invasive Breast Cancer".

Authors:  Antonio Ieni; Giovanni Tuccari
Journal:  J Breast Cancer       Date:  2016-03-25       Impact factor: 3.588

8.  Prognostic Impact and Clinicopathological Correlation of CD133 and ALDH1 Expression in Invasive Breast Cancer.

Authors:  Sung Jeep Kim; Yong Seok Kim; Eun Duok Jang; Kyung Jin Seo; Jeong Soo Kim
Journal:  J Breast Cancer       Date:  2015-12-23       Impact factor: 3.588

Review 9.  Aldehyde dehydrogenase as a marker and functional mediator of metastasis in solid tumors.

Authors:  Mauricio Rodriguez-Torres; Alison L Allan
Journal:  Clin Exp Metastasis       Date:  2015-10-07       Impact factor: 5.150

10.  Distinct prognostic values of alcohol dehydrogenase mRNA expression in pancreatic adenocarcinoma.

Authors:  Xiwen Liao; Rui Huang; Xiaoguang Liu; Chuangye Han; Long Yu; Shijun Wang; Na Sun; Bopei Li; Xin Ning; Tao Peng
Journal:  Onco Targets Ther       Date:  2017-07-24       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.